NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $256 | +3.2% | 2,500 | 0.0% | 0.02% | -5.9% |
Q2 2023 | $248 | +8.3% | 2,500 | 0.0% | 0.02% | 0.0% |
Q1 2023 | $229 | 0.0% | 2,500 | 0.0% | 0.02% | -15.0% |
Q4 2022 | $229 | -99.9% | 2,500 | 0.0% | 0.02% | 0.0% |
Q2 2022 | $211,000 | -3.7% | 2,500 | 0.0% | 0.02% | +5.3% |
Q1 2022 | $219,000 | -34.2% | 2,500 | -34.2% | 0.02% | -40.6% |
Q4 2021 | $333,000 | +7.4% | 3,800 | 0.0% | 0.03% | -15.8% |
Q3 2021 | $310,000 | -17.3% | 3,800 | -7.5% | 0.04% | -15.6% |
Q2 2021 | $375,000 | -32.2% | 4,110 | -36.4% | 0.04% | -39.2% |
Q1 2021 | $553,000 | -17.6% | 6,460 | -9.1% | 0.07% | -33.9% |
Q4 2020 | $671,000 | -22.2% | 7,110 | -28.4% | 0.11% | -36.4% |
Q3 2020 | $863,000 | -16.9% | 9,934 | -16.5% | 0.18% | -27.0% |
Q2 2020 | $1,039,000 | +5.3% | 11,903 | -0.6% | 0.24% | -24.0% |
Q1 2020 | $987,000 | -16.2% | 11,971 | -3.7% | 0.32% | -0.9% |
Q4 2019 | $1,178,000 | +8.0% | 12,433 | -1.0% | 0.32% | -0.9% |
Q3 2019 | $1,091,000 | -8.9% | 12,558 | -4.2% | 0.32% | -9.5% |
Q2 2019 | $1,198,000 | -38.9% | 13,115 | -35.7% | 0.36% | -40.9% |
Q1 2019 | $1,961,000 | -46.8% | 20,402 | -52.6% | 0.60% | +2.7% |
Q4 2018 | $3,688,000 | +119.9% | 43,074 | +121.5% | 0.59% | +119.4% |
Q3 2018 | $1,677,000 | -0.1% | 19,446 | -15.4% | 0.27% | -47.8% |
Q2 2018 | $1,678,000 | -58.6% | 22,990 | -54.1% | 0.51% | -59.9% |
Q1 2018 | $4,051,000 | -38.8% | 50,102 | -36.5% | 1.28% | -36.9% |
Q4 2017 | $6,623,000 | -3.0% | 78,881 | -2.1% | 2.02% | -9.7% |
Q3 2017 | $6,827,000 | +0.7% | 80,582 | -0.8% | 2.24% | -7.1% |
Q2 2017 | $6,777,000 | +5.9% | 81,192 | -5.7% | 2.41% | -3.4% |
Q1 2017 | $6,400,000 | +2.8% | 86,058 | +0.7% | 2.50% | -8.2% |
Q4 2016 | $6,225,000 | -9.5% | 85,452 | -2.0% | 2.72% | -6.7% |
Q3 2016 | $6,882,000 | -8.9% | 87,163 | -4.8% | 2.92% | -8.7% |
Q2 2016 | $7,553,000 | +11.3% | 91,538 | -2.3% | 3.19% | +9.2% |
Q1 2016 | $6,787,000 | -14.9% | 93,689 | +1.1% | 2.92% | -12.2% |
Q4 2015 | $7,972,000 | -5.7% | 92,656 | +0.7% | 3.33% | -6.7% |
Q3 2015 | $8,455,000 | -10.1% | 91,983 | -3.8% | 3.56% | -2.6% |
Q2 2015 | $9,402,000 | -2.4% | 95,607 | -2.1% | 3.66% | -2.0% |
Q1 2015 | $9,633,000 | +4.3% | 97,692 | -1.9% | 3.74% | +5.3% |
Q4 2014 | $9,232,000 | – | 99,593 | – | 3.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |